4 completed, 1 unknown. 4 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 3, Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Psychoses, Substance-Induced: new trials by email Literature Review of Psychoses, Substance-Induced trials Research Report on Psychoses, Substance-Induced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis OPUS YOUNG, Treatment as Usual - Schizophrenia, Schizotypal Disorder | Not applicable | Completed | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 284 | 2021-05-06 | 2026-08-20 |
| ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention Active SMS Intervention, Sham SMS - First Episode Psychosis, Psychosis | Not applicable | Completed | Centre for Addiction and Mental Health | 186 | 2020-09-21 | 2026-03-18 |
| Prevention of Weight Gain in Early Psychoses Behavioural Intervention for the Prevention of Weight Gain, TAU - Schizophreniform Disorder, Bipolar I Disorder | Not applicable | Completed | Centre for Addiction and Mental Health | 70 | 2010-02-01 | 2017-07-25 |
| AIMHI NT Relapse Prevention Trial Motivational Interview with care plan and education - Schizophrenia, Schizoaffective Disorder | Not applicable | Unknown | Menzies School of Health Research | 90 | 2005-07-01 | 2007-05-22 |
| Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids Ketamine, Dexmedetomidine - Psychoses, Substance-Induced | Phase 4 | Completed | Washington University School of Medicine | 40 | 2003-02-01 | 2016-01-14 |
Psychotic Disorders (4) · Schizophrenia (4) · Bipolar Disorder (3) · Affective Disorders, Psychotic (1) · Coronary Disease (1) · Depression (1) · Depressive Disorder, Major (1) · Memory Disorders (1) · Mental Disorders (1) · Schizophrenia Spectrum and Other Psychotic Disorders (1) · Schizophrenia, Paranoid (1) · Schizotypal Personality Disorder (1) · Weight Gain (1)
Chemically-Induced Disorders (5) · Poisoning (5) · Substance-Related Disorders (5) · Mental Disorders (4) · Schizophrenia Spectrum and Other Psychotic Disorders (4) · Bipolar and Related Disorders (3) · Mood Disorders (3) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Behavior (1) · Behavioral Symptoms (1) · Body Weight (1) · Body Weight Changes (1) · Cardiovascular Diseases (1) · Depressive Disorder (1)
Dexmedetomidine (1) · Educational Status (1) · Ketamine (1) · Motivational Interviewing (1) · Therapeutics (1)
Centre for Addiction and Mental Health (2) · Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (1) · Menzies School of Health Research (1) · Washington University School of Medicine (1)
Canada (2) · Australia (1) · Denmark (1) · United States (1)
Albert HC Wong, MD, PhD (1) · Anne K Pagsberg, PhD (1) · Aristotle N Voineskos, MD, PhD (1) · George Foussias, MD, PhD (1) · John W. Newcomer, M.D. (1) · Nicole Kozloff, MD, SM (1) · Rohan Ganguli, MD (1) · Tricia M Nagel, MBBS, FRANZCP (1) · Vicky Stergiopoulos, MD, MHSc (1)